Monitoring When Starting Cozaar (Losartan)
When initiating losartan, you must monitor renal function (serum creatinine) and serum potassium within 7-14 days after starting therapy, then periodically thereafter, as this is critical to prevent hyperkalemia and acute renal failure. 1, 2
Baseline Assessment (Before Starting)
Before initiating losartan, obtain the following:
- Serum creatinine and estimated GFR to assess baseline renal function 2
- Serum potassium to identify pre-existing hyperkalemia 2
- Blood pressure measurement 1
- Pregnancy test in women of childbearing potential (losartan is contraindicated in pregnancy) 2
Early Monitoring (First 1-2 Weeks)
Critical monitoring window at 7-14 days post-initiation:
- Serum potassium: Monitor for hyperkalemia, particularly in patients taking other drugs that increase potassium (potassium supplements, potassium-sparing diuretics, NSAIDs) 1, 2
- Serum creatinine/renal function: Watch for acute deterioration, especially in volume-depleted patients, those with renal artery stenosis, severe heart failure, or chronic kidney disease 2
- Blood pressure: Assess for symptomatic hypotension, particularly in volume- or salt-depleted patients 2
Ongoing Monitoring
Routine follow-up schedule:
- Blood pressure: Monitor regularly during treatment; patients with pre-existing hypertension should check weekly at home for the first month, then at 3 months and every 6 months thereafter 1
- Renal function and potassium: Recheck periodically, especially after dose adjustments 1, 2
- Clinical assessment: Monitor for signs of renal dysfunction or hyperkalemia at routine visits 1
High-Risk Populations Requiring Closer Monitoring
Patients at particular risk who need more frequent monitoring:
- Volume-depleted patients (on high-dose diuretics): Correct volume depletion before starting losartan to prevent symptomatic hypotension 2
- Renal artery stenosis or chronic kidney disease: These patients may experience acute renal failure as their renal function depends on the renin-angiotensin system 2
- Severe heart failure: Monitor closely for renal function deterioration 2
- Elderly patients: No dosage adjustment needed, but monitor renal function carefully 3, 4
- Patients on concomitant medications: Those taking potassium supplements, potassium-sparing diuretics, NSAIDs, or other drugs affecting potassium require more vigilant monitoring 1, 2
Critical Safety Considerations
Avoid these dangerous combinations:
- Never combine with ACE inhibitors or direct renin inhibitors: This increases risk of hyperkalemia and renal dysfunction 1, 5
- Avoid in pregnancy: Discontinue immediately if pregnancy is detected due to fetal toxicity 2
- Withhold or discontinue if clinically significant decrease in renal function occurs 2
Common Pitfalls to Avoid
- Failing to check potassium early: Hyperkalemia can develop rapidly, especially with concomitant medications 2
- Not correcting volume depletion first: This leads to symptomatic hypotension after the first dose 2
- Inadequate monitoring in CKD patients: These patients are at highest risk for acute renal failure 2
- Missing pregnancy screening: Losartan causes serious fetal harm in second and third trimesters 2